Last week, the US dollar advanced to a one-year high against other major currencies. It has gained over 3 percent post the US presidential election. The currency has been on a recovery path since the first week of October, in hopes that the US Central Bank will continue lowering interest rates.
Posts in category All News
Midcap Momentum Portfolio (24-11-2024)
@nil I have subscribed to 2 of Weekend’s small cases. In fact, my momentum journey started with these only. It sparked interest and I learnt and implemented.
I think he goes by price action only. As they don’t publicise their formulae, it is difficult to find out.
Typically, I have seen there are about 2 or 3 stocks that are different between our pf and Weekend for a similar universe. Further, I find that sometimes, we enter a week earlier or he enters a week later. So, the stocks are more or less the same.
FPI outflows continue in Nov at Rs 26,533 cr, pace of outflow slows (24-11-2024)
Foreign investors have pulled out Rs 26,533 crore from the Indian equity market this month so far owing to increasing allocations to China, concerns over muted corporate earnings and elevated valuation of domestic stocks.
While the sell-off continues, the quantum of net outflows has significantly reduced compared to October, when Foreign Portfolio Investors (FPI) withdrew Rs 94,017 crore (USD 11.2 billion) on a net basis.
With the latest pull-out, FPI outflows on a net basis are Rs 19,940 crore in 2024 so far.
Going ahead, the flows from foreign investors into the Indian equity markets would depend on the policies implemented under Donald Trump’s presidency, the prevailing inflation and interest rate dynamics, the trajectory of the geopolitical landscape, and the third-quarter earnings performance of Indian companies, Himanshu Srivastava, Associate Director – Manager Research, Morningstar Investment Research India, said.
According to the data, FPIs recorded a net outflow of Rs 26,5
FPI selling spree continues in Nov at Rs 26,533 cr, pace of outflow slows (24-11-2024)
Foreign investors have pulled out Rs 26,533 crore from the Indian equity market this month so far owing to increasing allocations to China, concerns over muted corporate earnings and elevated valuation of domestic stocks.
While the sell-off continues, the quantum of net outflows has significantly reduced compared to October, when Foreign Portfolio Investors (FPI) withdrew Rs 94,017 crore (USD 11.2 billion) on a net basis.
With the latest pull-out, FPI outflows on a net basis are Rs 19,940 crore in 2024 so far.
Going ahead, the flows from foreign investors into the Indian equity markets would depend on the policies implemented under Donald Trump’s presidency, the prevailing inflation and interest rate dynamics, the trajectory of the geopolitical landscape, and the third-quarter earnings performance of Indian companies, Himanshu Srivastava, Associate Director – Manager Research, Morningstar Investment Research India, said.
According to the data, FPIs recorded a net outflow of Rs 26,5
HDFC Life Insurance Company (24-11-2024)
Thanks for sharing, did they share the reason for this as otherwise Health insurance has good growth?
Smallcap momentum portfolio (24-11-2024)
Update for entry on 25th November 2024 (lookback dates: 24/11/2023 and 2405/2024)
50EMA (17,587) > 200EMA (16,480); hence, we can continue without any change.
Based on ranking:
- GVT&D
- SUVENPHAR
- DEEPAKFERT
- JUBLPHARMA
- NETWEB
- ANANTRAJ
- MOTILALOFS
- DOMS
- MCX
- GLENMARK
- ERIS
- KAYNES
- PPLPHARMA
- VIJAYA
- ABSLAMC
- FSL
- NATIONALUM
- AMBER
- JYOTICNC
- INDIACEM
Based on A → Z for easy tracking:
- ABSLAMC*
- AMBER*
- ANANTRAJ
- DEEPAKFERT
- DOMS
- ERIS
- FSL
- GLENMARK
- GVT&D
- INDIACEM
- JUBLPHARMA
- JYOTICNC*
- KAYNES
- MCX
- MOTILALOFS
- NATIONALUM*
- NETWEB
- PPLPHARMA
- SUVENPHAR
- VIJAYA*
Exits:
HSCL and INOXWIND make an exit.
GODFRYPHLP, NATCOPHARM and POLYMED stay within the top 25 and hence remain.
Entries:
ABSLAMC and VIJAYA make an entry.
AMBER, JYOTICNC and NATIONALUM cannot enter as there is no vacancy.
Note: The above information is provided for educational purposes only. Please consult your Financial advisor before any investment.
Mcap of 8 of 10 most-valued firms jump Rs 1.55 trn; HDFC Bank, TCS sparkle (24-11-2024)
Eight of the top-10 most valued domestic firms together added Rs 1,55,603.45 crore in market valuation last week, with HDFC Bank and Tata Consultancy Services emerging as the biggest gainers, in tandem with firm trend in equities.
Last week, the BSE benchmark zoomed 1,536.8 points, or 1.98 per cent, and the Nifty climbed 374.55 points, or 1.59 per cent.
The BSE benchmark Sensex jumped 1,961.32 points, or 2.54 per cent, to settle at 79,117.11 on Friday. The NSE Nifty soared 557.35 points or, 2.39 per cent, to 23,907.25.
From the top-10 pack, Reliance Industries and Life Insurance Corporation of India (LIC) were the laggards.
The market valuation of HDFC Bank jumped Rs 40,392.91 crore to Rs 13,34,418.14 crore, the most among the top-10 firms.
Tata Consultancy Services (TCS) added Rs 36,036.15 crore to Rs 15,36,149.51 crore in its valuation.
The valuation of ICICI Bank soared Rs 16,266.54 crore to Rs 9,01,866.22 crore and that of Infosys surged Rs 16,189.33 crore to Rs 7,90,151.83 .
Microcap momentum portfolio (24-11-2024)
Update for entry on 25th November 2024 (lookback dates: 24/11/2023 and 24/05/2024)
50EMA (24,515) > 200EMA (22,538); hence, we can continue without any change.
Based on ranking:
- STAR
- GRWRHITECH
- WOCKPHARMA
- CHOICEIN
- PGEL
- SUPRIYA
- NEULANDLAB
- TIPSMUSIC
- WABAG
- INOXGREEN
- SHILPAMED
- NAVA
- PRUDENT
- ZENTEC
- GANESHHOUC
- VMART
- OPTIEMUS
- SANSERA
- AMIORG
- MARKSANS
- KIRLPNU
- ORCHPHARMA
- AVALON
- KESORAMIND
- BANCOINDIA
Based on A → Z for easy tracking:
- AMIORG*
- AVALON*
- BANCOINDIA*
- CHOICEIN
- GANESHHOUC
- GRWRHITECH
- INOXGREEN
- KESORAMIND
- KIRLPNU
- MARKSANS
- NAVA
- NEULANDLAB
- OPTIEMUS
- ORCHPHARMA*
- PGEL
- PRUDENT
- SANSERA
- SHILPAMED
- STAR
- SUPRIYA
- TIPSMUSIC
- VMART
- WABAG
- WOCKPHARMA
- ZENTEC
Exits:
SARDAEN makes an exit.
GRAVITA, IIFLSEC and LTFOODS stay within the top 30 and hence remain.
Entries:
AMIORG makes an entry.
AVALON, BANCOINDIA and ORCHPHARMA cannot enter as there is no vacancy.
Note: The above information is provided for educational purposes only. Please consult your Financial advisor before any investment.